23 July 2010

Cancer Docs 'Frustrated' By Lack of Useful Info in Journal Articles

Adding more practical data from clinical trials would help physicians, patients, researchers say


This article has not necessarily been edited by Health24.

THURSDAY, July 22 (HealthDay News) -- Medical journals should include more clinical details in cancer research studies to help doctors better understand and utilize results, according to U.S. researchers.

They analyzed 262 articles published from 2005 to 2008 in the Journal of Clinical Oncology, The New England Journal of Medicine, the Journal of the National Cancer Institute, and the journals Cancer and Blood.

Only 11 percent of the articles offered all the information required by doctors in order to prescribe and monitor new cancer therapies, said the researchers at the University of Florida in Gainesville.

The dose of the drug was almost always reported in the articles, but only 43 percent reported what premedication was necessary, and only 42 percent provided details about adjusting dosages if the therapy proved toxic to patients.

The study was published in a recent issue of the Journal of the National Cancer Institute.

The authors made several recommendations -- such as a change in the way journal editors edit and report on clinical trials -- that would lead to a major shift in the publication of clinical trials.

"This study came out of our clinical frustration," Dr. Thomas George Jr., a member of the UF Shands Cancer Center and director of UF's gastrointestinal oncology program in the college of medicine, said in a university news release. "We were trying to teach our students and fellows how to care for patients with cancer and prescribe therapeutics safely. We had a really hard time finding the information we needed to provide care for these patients in the original scientific articles."

"I think it just boils down to willpower on the part of the journal editors to agree that this is an important need," he added. "I think the scientific community -- the publishers, the editors and even the investigators who conduct the studies -- have been appropriately focused on justifying the scientific methods and merits of the study. We're just taking it to the next logical step, which is, how do we apply these results to the masses of patients who need to benefit from scientific progress?"

More information

The U.S. National Institutes of Health has more about clinical trials.

(Copyright © 2010 HealthDay. All rights reserved.)


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst and Head of Advocacy Magdalene Seguin. For more information, visit

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules